Targeting DDX3 with a small molecule inhibitor for lung cancer therapy

Targeting DDX3 with a small molecule inhibitor for lung cancer therapy

Abstract Lung cancer is the most common malignancy worldwide and is a focus for developing targeted therapies due to its refractory nature to current treatment. We identified a RNA helicase, DDX3, which is overexpressed in many cancer types including lung cancer and is associated with lower survival...

Full description

Bibliographic Details
Main Authors: Guus M Bol, Farhad Vesuna, Min Xie, Jing Zeng, Khaled Aziz, Nishant Gandhi, Anne Levine, Ashley Irving, Dorian Korz, Saritha Tantravedi, Marise R Heerma van Voss, Kathleen Gabrielson, Evan A Bordt, Brian M Polster, Leslie Cope, Petra van derGroep, Atul Kondaskar, Michelle A Rudek, Ramachandra S Hosmane, Elsken van derWall, Paul J vanDiest, Phuoc T Tran, Venu Raman
Format: Article
Language:English
Published: Springer Nature 2015-05-01
Series:EMBO Molecular Medicine
Subjects:
DDX3
DNA repair
lung cancer
radiation‐sensitizing agent
small molecule inhibitor
Online Access:https://doi.org/10.15252/emmm.201404368

Internet

https://doi.org/10.15252/emmm.201404368

Similar Items